valine has been researched along with Liver Failure in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azizi, M; Barreiros, AP; Birklein, F; Emrich, T; Galle, PR; Geber, C; Heise, M; Hoppe-Lotichius, M; Lang, H; Mittler, J; Otto, G; Schad, A; Schmid, JC; Vollmar, J; Weyer, V; Zimmermann, T | 1 |
| Chu, CJ; Hou, MC; Huang, YH; Wu, SH | 1 |
| Adkison, KK; Berg, J; Dumont, E; Elko-Simms, L; Galloway, C; Gan, J; Gardner, S; Jones, LS; Marbury, T; Saunders, J; Smith, W; Stump, PJ | 1 |
| Alkan, M; Balkan, II; Mete, B; Ozaras, R; Tabak, F; Yemisen, M | 1 |
| Berg, T; Ferenci, P; Gschwantler, M; Herzer, K; Jimenez-Exposito, MJ; Peck-Radosavljevic, M; Petersen, J; Rockstroh, J; Spengler, U; van der Valk, M; Wedemeyer, H; Weiland, O; Welzel, TM; Zeuzem, S; Zhao, Y | 1 |
| Appelman, H; Bifano, M; Dimitrova, D; Fontana, RJ; Hindes, R; Hughes, EA | 1 |
6 other study(ies) available for valine and Liver Failure
| Article | Year |
|---|---|
Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study.
Topics: Adult; Aged; Amyloid Neuropathies, Familial; Biopsy; Child; Databases, Factual; Disease Progression; Echocardiography; Female; Heart Rate; Humans; Liver Failure; Liver Transplantation; Living Donors; Male; Methionine; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome; Valine | 2018 |
Successful treatment with sofosbuvir and daclatasvir plus ribavirin in acute hepatitis C-infected patient with hepatic decompensation.
Topics: Acute Disease; Aged; Antiviral Agents; Carbamates; Drug Therapy, Combination; Hepatitis C; Humans; Imidazoles; Liver Failure; Male; Pyrrolidines; Ribavirin; RNA, Viral; Sofosbuvir; Sustained Virologic Response; Valine | 2019 |
Pharmacokinetics of hepatitis C virus NS5A inhibitor JNJ-56914845 (GSK2336805) in subjects with hepatic impairment.
Topics: Adult; Antiviral Agents; Area Under Curve; Carbamates; Female; Half-Life; Hepacivirus; Humans; Liver Failure; Male; Middle Aged; Valine; Viral Nonstructural Proteins | 2015 |
Successful treatment of post-transplant hepatitis C virus cirrhosis with daclatasvir and asunaprevir.
Topics: Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Isoquinolines; Liver Failure; Liver Transplantation; Middle Aged; Pyrrolidines; Sulfonamides; Treatment Outcome; Valine; Virus Activation | 2015 |
Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Cohort Studies; Compassionate Use Trials; Drug Monitoring; Drug Therapy, Combination; Europe; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver Failure; Male; Middle Aged; Pyrrolidines; Ribavirin; Severity of Illness Index; Sofosbuvir; Treatment Outcome; Valine | 2016 |
Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation.
Topics: Alkaline Phosphatase; Antiviral Agents; Bilirubin; Biomarkers; Carbamates; Cholestasis; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Imidazoles; Immunosuppressive Agents; Interferon-alpha; Liver Failure; Liver Transplantation; Middle Aged; Polyethylene Glycols; Pyrrolidines; Recombinant Proteins; Recurrence; Reoperation; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Valine; Viral Load | 2012 |